|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-10-10
|
|
pubmed:abstractText |
Using statistical parametric mapping and 11C-flumazenil (FMZ) PET we have previously shown reduction of central benzodiazepine receptor (cBZR) binding restricted to the hippocampus in mesial temporal lobe epilepsy (mTLE) due to hippocampal sclerosis (HS). The limited spatial resolution of PET, however, results in partial-volume averaging that affects quantitative analysis of cBZR density.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
764-73
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9305338-Adult,
pubmed-meshheading:9305338-Brain Diseases,
pubmed-meshheading:9305338-Carbon Radioisotopes,
pubmed-meshheading:9305338-Epilepsy, Temporal Lobe,
pubmed-meshheading:9305338-Female,
pubmed-meshheading:9305338-Flumazenil,
pubmed-meshheading:9305338-Hippocampus,
pubmed-meshheading:9305338-Humans,
pubmed-meshheading:9305338-Magnetic Resonance Imaging,
pubmed-meshheading:9305338-Male,
pubmed-meshheading:9305338-Middle Aged,
pubmed-meshheading:9305338-Sclerosis,
pubmed-meshheading:9305338-Tomography, Emission-Computed
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
|
|
pubmed:affiliation |
MRC Cyclotron Unit, Hammersmith Hospital, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
